The VELOCIMMUNE brand, founded in 2002 (United States), from
16 sister brands
and 2214 competing brands.
VELOCIMMUNE is owned by Regeneron Pharmaceuticals, listed on the stock exchange of New York
The sector of VELOCIMMUNE is Biotechnology.
VELOCIMMUNE is a brand of Regeneron Pharmaceuticals (REGN) News
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.